What is thrombocytopenia induced by heparin?

heparin-indeinated thrombocytopenia (HIT) is a blood disorder where plate levels decrease in response to the autoimmune reaction by running heparin, anticoagulant drugs. Some cases are mild and simply require alert waiting. Others are more serious and may be fatal unless the doctor provides early treatment. In patients taking heparin, this condition is a known risk and the physician usually asks for a regular blood number to ensure that the levels of the plates remain in the safe range. When the plates are activated, their number in the body is exhausted as long as they can be replaced, so the number of plates will drop. In addition, activation can cause clotting, causing dangerous clots to form inside the patient's blood vessels. Since patients are on heparin to treat or prevent these thromboses, the expansion of existing clots or new formation is a serious medical problem.

type and this condition within two days of administration of heparin. Patients with thrombocytopeniaOlan Heparin type II does not have to develop a reaction for one week or more. There are usually no apparent symptoms until the blood clot increases sufficiently to cause a problem. The patient's limbs may be in danger because the reduced blood flow can lead to tissue necrosis and there is also a risk of brain or pulmonary embolism if the precipitate is released and freely circulates the patient's body.

Some patients with heparin induced thrombocytopenia experience an immediate infusion response when they receive this medicine. They will develop rashes, fever, chills and chest pain. These symptoms of severe reactions can be immediately dealt with by doctors and nurses who can stop infusion and evaluate the patient for clot formation. In other patients, clotting may not start to recruit only after anticoagulance interruption, which is important for people with a history of anticoagulant use to detect their doctors when they receiveTreatment for blood disorders.

Treatment of thrombocytopenia caused by heparin involves the stopping of drugs and treatment of clotting. It is often necessary to administer another anticoagulant to break the clots and replace heparin. The patient may need surgery and other treatment depending on the position, size and severity of the clots. Patients with this reaction should also make sure that their graphs reflect it because, in addition to heparin, other anticoagulants such as warfarin may be dangerous for patients with a history of heparin induced thrombocytopenia.

IN OTHER LANGUAGES

Was this article helpful? Thanks for the feedback Thanks for the feedback

How can we help? How can we help?